Hanson McClain Advisors »

Inhibrx Biosciences shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $337 5 67.40

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds State Street Spd (SPDW)
Spdr Series Trust State Street Spd (SPYG)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds State Street Spd (SPEM)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Gmo Etf Trust Gmo Us Quality E (QLTY)

View all positions for Hanson McClain Advisors

Top funds holding Inhibrx Biosciences

Perceptive Advisors
Viking Global Investors
Morgan Stanley
Sanofi
HighTower Advisors
BlackRock
State Street Corporation
Vanguard Capital Management
Sofinnova Ventures
Capital Research Global Investors
Woodline Partners
Millennium Management
Partner Fund Management
Schonfeld Strategic Advisors
Geode Capital Management

View all funds holding Inhibrx Biosciences